British Journal of Haematology · 1995 · 104 citations · 35 references
Life SciencesHematologyImmunologyCellular ImmunologyStem Cell TransplantationTransplant ImmunologyCord Blood TransplantationDonor MatchingHla MatchingImmune Cell DifferentiationNatural Killer Cell BiologyT Cell BiologyCord Blood CellsCord Blood MatchingDonor-recipient ImmunologyStem Cell Donor MatchingUmbilical Cord Blood Natural Killer CellsUmbilical Cord Blood Stem Cells
Cord blood has been used successfully for stem cell transplantation in several haematological conditions: Fanconi's anaemia, leukaemia and Wiskott-Aldrich syndrome. On account of the low incidence of GVHD observed following cord blood transplantation, it has been suggested that cord blood be used for HLA-matched, or perhaps one or two antigens mismatched, and unrelated stem cell transplantation. Based on an extensive immunophenotype-functional correlation, we determined that cord blood contains mainly immature unprimed T lymphocytes that are predominantly suppressor cells. Recent findings suggest that dysregulated production of cytokines (IL-1, IL-2, TNF alpha) plays a role in GVHD. We showed that T cells in cord blood express receptors for IL-2, TNF alpha, but no receptors for IL-1. Similarly, NK cells, one of the effector cells of GVHD, express receptors for TNF alpha and gamma IFN but do not express receptors for IL-1, nor IL-2R alpha-chain (CD25) although IL-2R beta-chain is expressed. The potential for activation of T lymphocytes and NK cells therefore exists in the context of bone marrow transplantation. However, the high number of suppressor cells in cord blood most likely modulate the activation of lymphocytes and NK cells thereby minimizing GVHD.
35
Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.
Arne N. Akbar, Linda A. Terry, Anthony Timms et al. · The Journal of Immunology · 1988 · 925 citations · Full text
Martin E. Sanders, Malegapuru W. Makgoba, Susan O. Sharrow et al. · The Journal of Immunology · 1988 · 912 citations